Ionis Pharmaceuticals, Inc.   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Carlsbad CA United States (1989)

Organization Overview

First Clinical Trial
1999
NCT00002156
First Marketed Drug
1998
fomivirsen sodium (vitravene)
First NDA Approval
1998
fomivirsen sodium (vitravene)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CARLSBAD | Hepasense | Ionis Pharmaceuticals | Ionis Pharmaceuticals, Inc. | Isis Pharmaceuticals | VP, Clinical Development, Isis Pharmaceuticals